Ready-to-use (RTU) containers are gaining momentum in pharmaceutical operations. However, many drug manufacturers are still looking for the optimal method to transfer presterilised containers into the fill-finish area of a filling line. Machine and technology supplier, Syntegon, and drug containment solutions provider, Stevanato Group, conducted an industry first series of experiments to explore the potential of vaporised hydrogen peroxide (H_2O_2 or VHP) for outside surface decontamination of RTU vials in trays or tubs/nests. Their results prove that the method increases both flexibility and efficiency during small batch manufacturing.It comes as no surprise that the market for RTU containers has been growing at a rapid pace during the past few years. Drug manufacturers benefit from reduced time-to-market and total cost of ownership (TCO), as well as increased flexibility and greater integrity of the drug product. From vials to syringes to cartridges, their numbers have increased consistently as more and more pharmaceutical manufacturers turn to small batch manufacturing. According to a recent market research, the market size for RTU vials alone reached $306.5 million in 2020. With an estimated market growth rate of 14.5 CAGR during the next decade, PS Intelligence predicts that the RTU vials market revenue will reach $1183.4 million worldwide by 2030.
展开▼
